Citigroup’s Silo Pharma SILO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-230
Closed -$1.19K 6356
2025
Q4
$1.17K Buy
+230
New +$1.7K ﹤0.01% 5532
2025
Q3
Sell
-724
Closed -$6.85K 6298
2025
Q2
$6.85K Buy
724
+622
+610% +$7.13K ﹤0.01% 5241
2025
Q1
$1.79K Sell
102
-77
-43% -$1.72K ﹤0.01% 5346
2024
Q4
$2.4K Buy
+179
New +$2.77K ﹤0.01% 5539

Other funds holding SILO

Citigroup's SILO Position: Q1 2026 in Review

Citigroup sold out of Silo Pharma (SILO) in Q1 2026, closing a stake of 230 shares — an estimated $1.19K sold.

Citigroup first reported a position in SILO in Q4 2024 and held it in 4 quarters. The position peaked at $6.85K in Q2 2025. 14 funds tracked by Wall St. Rank hold SILO as of Q1 2026.

  • Citigroup reported no remaining Silo Pharma position as of Q1 2026 after selling out during the quarter.
  • Citigroup sold 230 Silo Pharma shares in Q1 2026, an estimated $1.19K.
  • Citigroup first reported a position in Silo Pharma in Q4 2024 and held it in 4 quarters.
  • Citigroup's Silo Pharma position peaked at $6.85K in Q2 2025.
  • 14 funds tracked by Wall St. Rank held Silo Pharma as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.